LPAR5 and melanoma: We also extended our previous findings to show that B16 melanoma growth remains significantly restrained by Lpar5−/− tumor-specific CD8 T cells over 2 weeks after transfer [twice as long as previously shown (39)] and compared to the transfer of wild type tumor-specific CD8 T cells (Figure 4F).